SBW Life Sciences Co.,Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 0.00001 million compared to KRW 1,508.81 million a year ago. Net loss was KRW 9,228.91 million compared to KRW 3,608.33 million a year ago. Basic loss per share from continuing operations was KRW 52 compared to KRW 24 a year ago. Diluted loss per share from continuing operations was KRW 52 compared to KRW 24 a year ago. Basic loss per share was KRW 52 compared to KRW 24 a year ago.
For the six months, sales was KRW 0.00001 million compared to KRW 1,508.81 million a year ago. Net loss was KRW 8,521.93 million compared to KRW 3,029.42 million a year ago. Basic loss per share from continuing operations was KRW 49 compared to KRW 20 a year ago. Diluted loss per share from continuing operations was KRW 49 compared to KRW 20 a year ago. Basic loss per share was KRW 49 compared to KRW 20 a year ago.